Fig. 1From: Antitumor effects of the small molecule DMAMCL in neuroblastoma via suppressing aerobic glycolysis and targeting PFKLDMAMCL induced NB cell apoptosis in vitro. Four NB cell lines (NGP, AS, KCNR, BE2) and NIH3T3 cells were treated with different DMAMCL concentrations. A Cell confluence was monitored dynamically using Incucyte ZOOM for 72 h, ns (not significant): control vs DMAMCL treatment, *p < 0.05; **p < 0.01; ***p < 0.001. B Cell survival was detected using a CCK-8 assay at 72 h. C Colony formation assays were performed in the four NB cells and NIH3T3. Data were presented as mean ± SD. D Cell cycle was analyzed by detecting the percentage of PI-staining cells at each stage using flow cytometry at 48 h treatment of DMAMCL. E Cell apoptosis was detected using Annexin V-PE/7-AAD flow cytometry at 48 h. Data represent the mean ± SD of three independent experiments. F Cleaved PARP expression was detected using western blotting after DMAMCL treatment for 0, 8, 16 and 24 hBack to article page